Amaro Therapeutics is pioneering small-molecule agonists of extra-oral bitter taste receptors to treat diseases driven by metabolic dysfunction, chronic inflammation, and cellular senescence
Amaro Therapeutics is pioneering small-molecule agonists of extra-oral bitter taste receptors to treat diseases driven by metabolic dysfunction, chronic inflammation, and cellular senescence.